CRITICAL PATH INSTITUTE LAUNCHES NEW iTUNES APP
Created to facilitate patient participation in accurately tracking and communicating medication use
Tucson, Arizona, September 21, 2011– Critical Path Institute (C-Path), in cooperation with app co-developer, Scientific Technologies Corporation (STC), has just launched MyMedsList, which is available on iTunes for iPhone, iPad, and iPod Touch.
The application was created to encourage patients to keep better track of the medications they are taking, including prescription drugs, over-the-counter (OTC) products, dietary supplements, and vitamins, and builds on the capabilities provided by C-Path’s www.mymedslist.org website.
Users can create an electronic record of the medications they, or their family members, take, along with the prescriber and pharmacy information associated with those medications. This record can then be printed or emailed to share with doctors, pharmacists, and other healthcare providers, who can then more effectively prevent adverse reactions and interactions between the medicines, foods, or supplements being taken by those patients. To maintain privacy, the information is fully controlled by the user and is only recorded on the user’s electronic device.
“C-Path is committed to improving the development of new medications, as well as promoting safe medication use. We believe that the MyMedsList app is a great tool to help patients and their healthcare providers work as a team to monitor medications being taken, increasing the likelihood of medication benefit,” said Raymond Woosley, MD, PhD, President and CEO of C-Path.
To purchase, go to Apple’s iTunes Store and search MyMedsList. The app costs $.99 to download. The revenues will be used to develop additional features for this app and develop other apps to promote safe medication use.
About Critical Path Institute (C-Path): An independent, non-profit organization established in 2005 with public and private philanthropic support from the Southern Arizona community, Science Foundation Arizona (SFAz), and the U.S. Food and Drug Administration (FDA), C-Path is committed to improving health and saving lives by accelerating the development of safe, effective medicines. An international leader in forming collaborations around this mission, C-Path has established global, public-private partnerships that currently include over 1,000 scientists from government regulatory agencies, academia, patient advocacy organizations, and thirty five major pharmaceutical companies. C-Path is headquartered in Tucson, Arizona, with offices in Phoenix, Arizona, and Rockville, Maryland. For more information, visit www.c-path.org and follow us on Facebook. Click here to view a video showing why the work of C-Path is essential.
About Scientific Technologies Corporation (STC): STC, which provided design and technical support during the development of MyMedsList, is widely recognized as a leading public health informatics company in the U.S. STC plays a key role in protecting the public from diseases and leverages more than twenty-three years of experience to develop solutions important to addressing and solving critical public health issues. STC improves public health through the applied use of population health data collected through modernized information systems. STC offers a unique blend of public health advisors and applied information system developers who come together to create cost effective public health technology solutions. For more information, visit http://www.stchome.com.